Comparison of Ferric Carboxymaltose and Oral Iron Treatments in Iron Deficiency Anemia
نویسندگان
چکیده
منابع مشابه
Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia
Objective. To evaluate safety and efficacy of intravenous ferric carboxymaltose (FCM) versus standard medical care (SMC) for iron-deficiency anemia (IDA) in postpartum women and women with heavy menstrual bleeding. Study Design. This open-label, multicenter study randomized women with IDA (hemoglobin ≤ 11.0 g/dL) to single doses of FCM (15 mg/kg [maximum 1000 mg]) or SMC (this treatment was det...
متن کاملIntravenous ferric carboxymaltose for the treatment of iron deficiency anemia
Nutritional iron deficiency anemia is the most common deficiency disorder, affecting more than two billion people worldwide. Oral iron supplementation is usually the first choice for the treatment of iron deficiency anemia, but in many conditions, oral iron is less than ideal mainly because of gastrointestinal adverse events and the long course needed to treat the disease and replenish body iro...
متن کاملComparison of Intravenous Iron Sucrose and Ferric Carboxymaltose Therapy in Iron Deficiency Anemia during Pregnancy and Postpartum Period
Objective of presented study was to compare intravenous iron sucrose and ferric carboxymaltose therapy in iron deficiency anemia during pregnancy and postpartum period. Methods: A clinical observational study was undertaken at tertiary care teaching hospital over a period of 4 months in 30 pregnant women and 30 post partum women. The baseline hemoglobin and serum ferritin levels were recorded p...
متن کاملDirect Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia
Several intravenous iron complexes are available for the treatment of iron deficiency anemia (IDA). Iron dextran (DEX) is associated with an elevated risk of potentially serious anaphylactic reactions, whereas others must be administered in several small infusions to avoid labile iron reactions. Ferric carboxymaltose (FCM) is a nondextran intravenous iron which can be administered in high singl...
متن کاملFerric carboxymaltose in patients with heart failure and iron deficiency.
BACKGROUND Iron deficiency may impair aerobic performance. This study aimed to determine whether treatment with intravenous iron (ferric carboxymaltose) would improve symptoms in patients who had heart failure, reduced left ventricular ejection fraction, and iron deficiency, either with or without anemia. METHODS We enrolled 459 patients with chronic heart failure of New York Heart Associatio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kafkas Journal of Medical Sciences
سال: 2020
ISSN: 1307-4504
DOI: 10.5505/kjms.2020.88709